Skip Navigation



Carcinogenesis Advance Access published online on August 1, 2008
Carcinogenesis, doi:10.1093/carcin/bgn179
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
29/11/2175    most recent
bgn179v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Xiang, N.
Right arrow Articles by Zhong, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiang, N.
Right arrow Articles by Zhong, W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Selenite Reactivates Silenced Genes by Modifying DNA Methylation and Histones in Prostate Cancer Cells

Nong Xiang1, Rui Zhao1, Guoqing Song1 and Weixiong Zhong1,2,*

1 The Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
2 Pathology and Laboratory Medicine Service, William S. Middleton Memorial Veterans Hospital, Madison, WI 53705, USA

* To whom correspondence should be addressed: Tel: +1 608 265 6069; Fax: +1 608 265 6215; E-Mail: wzhong3{at}wisc.edu

DNA hypermethylation is a common epigenetic alteration in human prostate cancer and is considered to contribute to development of this disease. Accumulating data suggest that dietary factors may alter cancer risk by modifications of epigenetic processes in the cell. The present study was designed to investigate whether selenium would alter epigenetic events to regulate methylation-silenced genes in human prostate cancer cells. DNA methylation, histone modifications, and gene expression were studied in LNCaP cells after selenite treatment using PCR, western blot analysis, chromatin immunoprecipitation (ChIP) assay, and enzymatic activity assay. Our study shows that selenite treatment caused partial promoter DNA demethylation and reexpression of the {pi}-class glutathione-S-transferase (GSTP1) in LNCaP cells in a dose- and time-dependent manner. Selenite treatment decreased mRNA levels of DNA methyltransferases (DNMT) 1 and 3A, and protein levels of DNMT1. Selenite also decreased histone deacetylase activity and increased levels of acetylated lysine 9 on histone H3 (H3-Lys 9), but decreased levels of methylated H3-Lys 9. Selenite treatment reduced levels of DNMT1 and methylated H3-Lys 9 associated with the GSTP1 promoter, but increased levels of acetylated H3-Lys 9 associated with this promoter. Additionally, selenite treatment decreased general DNA methylation and caused partial promoter demethylation and reexpression of the tumor suppressor adenomatous polyposis coli (APC) and cellular stress response 1 (CSR1), a gene involving tumor growth and metastasis. Our study demonstrates that selenium can epigenetically modulate DNA and histones to activate methylation-silenced genes. These epigenetic modifications may contribute to cancer prevention by selenium.

Key Words: acetylation • DNA • gene expression • histone • methylation • prostate cancer • selenium

Received March 8, 2008; revised July 28, 2008; accepted July 29, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.